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Genetically engineered mice have been essential tools for elucidating the pathological mechanisms underlying human diseases.
In the case of diseases caused by impaired desmosome function, mouse models have helped to establish causal links between
mutations and disease phenotypes. This review focuses on mice that lack the desmosomal cadherins desmoglein 3 or desmocollin
3 in stratiﬁed epithelia. A comparison of the phenotypes observed in these mouse lines is provided and the relationship between
the mutant mouse phenotypes and human diseases, in particular pemphigus vulgaris, is discussed. Furthermore, we will discuss
the advantages and potential limitations of genetically engineered mouse lines in our ongoing quest to understand blistering skin
diseases.
1.Introduction
I nr e c e n ty e a r s ,m o u s em o d e l sh a v eb e c o m ea ne s s e n t i a lt o o l
for studying genetic diseases, especially in cases where the
disease is caused by mutations in a single gene (monogenic
disorders). It has been a challenge, however, to faithfully
reproduce the pathophysiology of autoimmune disorders in
mice, in part because the human disease is inﬂuenced by
complex factors such as the genetic background, the nature
of the autoantibodies (epitopes recognized and antibody
subclass) and titers of the circulating autoantibodies.
Pemphigus is a class of autoimmune blistering skin
diseases which manifest itself in the form of painful lesions
in the skin and oral mucosa and which, in the case of
pemphigus vulgaris, can be lethal if left untreated. The
sera of patients with pemphigus contain autoantibodies
directed against desmosomal cadherins (e.g., desmogleins
and most likely desmocollins; see below) [1, 2], a group of
transmembrane glycoproteins that are required to establish
and maintain cell-cell adhesion between epidermal ker-
atinocytes (reviewed in [3]). Desmogleins and desmocollins
are transmembrane glycoproteins that are thought to estab-
lish cell coupling via binding of their extracellular domains.
On the cytoplasmic surface of the plasma membrane,
these cadherins are connected to the intermediate ﬁlament
cytoskeleton via a network of desmosomal plaque proteins
(desmoplakin, plakoglobin, plakophilins).
How does the binding of pathogenic pemphigus autoan-
tibodies induce intraepithelial blistering, the characteristic
histopathological feature of the disease? Do these antibodies
inhibit the function of these proteins? A simple approach
to test this hypothesis is to eliminate the target protein in
genetically engineered mice and to determine whether the
resulting loss-of-function phenotype replicates the disease.
Pemphigus vulgaris (PV) patients develop autoantibod-
ies that target desmoglein (DSG) 3 and under certain condi-
tionsdesmoglein(DSG)1[1].PatientswithDSG3antibodies
alone develop mucous membrane lesions whereas, in the
presence of both DSG3 and DSG1 antibodies, skin lesions
a r eo b s e rv e da sw e ll[ 1]. Furthermore, it has been shown that
injecting DSG3-speciﬁc PV antibodies into newborn mice
can replicate the histopathology of the disease, demonstrat-
ing the pathogenicity of these antibodies (see [1]).
Based on the assumption that autoantibodies neutralize
adhesive functions, one would predict that loss of Dsg3 func-
tion in mice would mimic the phenotype of PV restricted
to mucous membranes. To test this hypothesis, we generated
Dsg3 null mice.2 Dermatology Research and Practice
2. Null Mutation in Dsg3 ProvidedFirst
FunctionalLinkto PV
Mice with a targeted disruption of Dsg3 exhibited pheno-
types very similar to those seen in PV patients and provided
direct evidence for a role of DSG3 in maintaining cell-cell
adhesion between keratinocytes. A hallmark feature of PV
in humans is acantholysis (loss of cell-cell adhesion) just
above the basal layer in stratiﬁed epithelia. Furthermore,
basal keratinocytes often lose lateral cell contact, leading
to a histological ﬁnding that has been called a “row of
tombstones”. The Dsg3-null mice developed severe erosions
of the oral mucosa (similar to that seen in PV patients)
that prevented them from feeding thus causing runting.
Suprabasal blistering was also evident in other stratiﬁed
epithelia such as the vaginal epithelium (see below). Overt
skin lesions were not noted in these mice, except for areas
exposed to signiﬁcant mechanical stress such as the skin
around the snout, the nipples of nursing females, and the
muco-cutaneous junctions in the eyes [4, 5]. A histological
examination of other mouse tissues that express DSG3, such
as the esophagus, the forestomach (which is lined by a
stratiﬁed epithelium structurally similar to the epidermis),
and the thymus, did not reveal abnormalities. Note that the
forestomach is a characteristic feature of the mouse which is
not present in humans.
A likely explanation for the absence of lesions in these
tissues lies in the expression of functionally redundant
desmogleinisoformswhichcompensateforthelossofDSG3.
This idea is consistent with the compensation hypothesis,
put forward by John Stanley and colleagues (see [2]), to
explain the tissue-speciﬁcity of pemphigus autoantibodies.
Based on this idea, one would predict that DSG3 is the
predominant or the only DSG isoform expressed in the area
where acantholysis occurs (e.g., in the deep layers of the oral
mucosa).Further,extensiveoverlapbetweenDSG3andother
DSG isoforms should exist in tissues and cell layers where no
spontaneous lesions were detected. The distribution of the
three major DSG isoforms (DSG1–3) in aﬀected (mucous
membranes) and unaﬀected tissues (e.g., skin) appears to
be largely consistent with this idea as illustrated in Figure
1. In the skin of mice, DSG3 is restricted to the basal
and immediate suprabasal cell layers, whereas DSG1 and 2
are present throughout the epithelium. Thus, DSG1 and 2
ensure that cell-cell adhesion is maintained in Dsg3 null skin
(Figure 1). Nevertheless, traumatizing the skin by rubbing or
scratching resulted in lesions, indicating that in the absence
of DSG3, the mechanical strength of the epithelial tissue
was compromised. In mucous membranes, DSG1 and 2 are
presentthroughouttheepitheliumbutareweakerinthedeep
epidermis where DSG3 dominates as judged by immunohis-
tochemical staining (Figure 1(b)), thus explaining the PV-
like acantholysis observed in Dsg3 null oral mucosa.
3. Loss of Dsc3 andDsg3 LeadtoSimilar
Histopathology butTarget DifferentTissues
Desmosomal adhesion is thought to be mediated both by
homophilic as well as by heterophilic interactions between
desmogleins anddesmocollins, whichformtheadhesivecore
of desmosomes (e.g., [6, 7]). The relative contributions of
homophilic (DSG-DSG; DSC-DSC) and heterophilic (DSG-
DSC)interactionstoestablishandmaintaincelladhesionare
currently not known. In the case of DSG3, it had originally
been speculated that a DSG3-DSC3 complex might be
essentialtomaintainkeratinocyteadhesioninthedeeplayers
of stratiﬁed epithelia (for an alternative view see [6]). We
thus hypothesized that ablating Dsc3 in mice might mimic
the eﬀectsof loss of DSG3, leading to PV-like histopathology.
Since germline deletion of the Dsc3 gene was embryonic
lethal [8], conditional Dsc3 null mutant mouse lines were
generated that lacked DSC3 expression in basal keratinocytes
of stratiﬁed epithelia, including skin and mucous mem-
branes [9]. These tissue-speciﬁc Dsc3 null mice developed
skin blisters (Figures 2(a) and 2(b)) that were histologically
similar to those found in humans with muco-cutaneous
PV. In contrast to skin lesions in Dsg3-null mice (which
were restricted to areas exposed to signiﬁcant mechanical
trauma),Dsc3nullskinblistersdevelopedspontaneouslyand
were present in all skin samples of newborn mice that were
analyzed. Nevertheless, the extent of blister formation varied
between individual mice, most likely due to diﬀerent degrees
of mechanical stress to which the animals were exposed prior
to tissue harvesting. Even small trauma resulted in extensive
skin blistering in Dsc3 null skin, a typical characteristic of PV
in humans (Nikolsky’s sign).
Unlike the lesions observed in Dsg3-null mutants (Fig-
ures 2(c) and 2(d)), lesions in the Dsc3 null mice were
restricted to the skin and were not present in internal
stratiﬁed epithelia, such as those of the oral cavity. As in the
case of the Dsg3-null mice, we believe that the restriction
of the blistering phenotype to the skin can be explained
by the expression of compensatory proteins, in this case
DSC isoforms. In the skin, DSC3 is present throughout the
epithelium with weaker expression levels in the granular
layers (Figure 1). DSC1 is mainly restricted to the granular
cell layer of the interfollicular epidermis. The distribution of
DSC2 in the mouse epidermis is currently not known, due
to the lack of antibodies that recognize the mouse isoform.
Nevertheless, in humans and cows, it is known that Dsc2
is only weakly expressed or even absent in most of the
interfollicular epidermis, with the notable exception of the
palms and soles (see [9]). Given that the DSC1 and DSC3
expression patterns are very similar in mice and humans,
it is reasonable to speculate that the distribution of DSC2
is also very similar in both species. Consequently, DSC3
would be the major DSC isoform expressed in the deep
layers of the epidermis, thus explaining why loss of Dsc3
causes acantholysis in these cell layers. How to explain the
absence of lesions in the oral cavity of Dsc3 mutants? We
believe that the key to understanding the tissue speciﬁcity of
these lesions is the distribution of DSC2. Data from bovine
samples indicated that Dsc2 is strongly expressed throughout
all layers of internal stratiﬁed epithelia, such as tongue [10–
13]. The combination of DSC1 and DSC2 is thus likely to
maintain cell-cell adhesion in oral mucosa in the absence
of DSC3 (Figure 1, and data not shown). Nevertheless,











































































































































Figure 1: Expression of the desmosomal cadherins desmoglein 1, 2, and 3 (DSG1–3) and desmocollin 1 and 3 (DSC1, 3) as well as α6-
integrin (ITGA6) in the interfollicular epidermis and the tongue epithelium of mice: Immunoﬂuorescence staining of newborn epidermis
((a), (e), (c), (g)) and adult tongue ((b), (d), (f), (h)). The cadherins are shown in green while the integrin is shown in red. ((i), (j), (k),
(l)) Schematic representation of the distribution of each desmosomal cadherin in the epidermis ((i), (k)) and tongue epithelium ((j and l)).
Note that DSC2 antibodies which recognize the mouse isoform are currently not available (see text for details). Immunoﬂuorescence signals
from the stratum corneum are due to nonspeciﬁc binding of secondary antibodies (white bar). Cell layers expressing the relevant proteins
are marked with brackets. The white arrow in (g) points towards the basal layer, which does not synthesize DSC1. Note that the expression
of DSG1+2 in the tongue is low in the basal layers. (i, j, k, l) Distribution of the desmosomal cadherins in stratiﬁed epithelia (BL, basal layer;










Figure 2: Acantholysisin theinterfollicular epidermis and mucousmembranes ofDsc3andDsg3 nullepithelia. (a)Acantholysisbetween the
basal and ﬁrst suprabasal layer in the back skin epidermis of newborn conditional Dsc3 null mice (Dsc3fl/fl/K14-Cre). (b) Severe skin lesions
of a 140 day-old Dsc3fl/fl/K14-Cre mouse showing blistering in a healing wound. Note that these mice enter a cycle in which acantholysis
triggers epithelial tongue formation and secondary blistering in the epithelium that covers the original wound. (c) Tongue section from a
25-day-old Dsg3 null mouse showing acantholysis and massive inﬂammation in the epithelium. (d) Vagina of a 6-month-old Dsg3 null
mouse showing acantholysis in the deep epithelium (between basal and suprabasal layer). (e) Back skin of an adult wild type mouse.
(f) Tongue histology of an adult wild type mouse. Stars indicate blister cavities.
heterophilic) interactions between desmosomal cadherins in
vivo; that is, other models of compensation are possible.
Given that homophilic interactions between desmosomal
cadherins might occur in vivo, it is also possible that DSG3-
DSG3 interactions alone might be suﬃcient to maintain cell
adhesion in the Dsc3 null mucosa.
The data summarized above suggest that DSG3 and
DSC3 have comparable functions in desmosomes. However,
they have diﬀerent roles in cell adhesion of speciﬁc tissues,
due to the presence of diﬀerent compensatory proteins in
diﬀerent tissues. Thus, whereas DSG3 appears to be essential
for maintaining cell-cell adhesion of internal stratiﬁedDermatology Research and Practice 5
epithelia, DSC3 plays a similar role in the epidermis of the
skin.
4. NullMutations in Desmosomal Cadherins
CauseHairLoss
Interestingly, both desmosomal cadherins are required to
anchor hair follicles in the skin, as demonstrated by the
cyclic hair loss observed both in Dsg3 null and Dsc3 null
mice (Figure 3). The hair loss in both mutants was initiated
around the time of weaning and progressed from the top
of the head to the tail. This hair loss was never observed
in wild type litter mates, that is, this phenotype was strictly
linkedtothenullmutationsinthetwodesmosomalcadherin
genes. Further, loss of telogen hair, as demonstrated by
tape hair-stripping experiment (Figures 5(c) and 5(g)), was
observed only in the mutant animals and not in wild type
littermates. Histology of the bald areas of the skin revealed
intraepithelial blistering aﬀecting the two keratinocyte cell
layers surrounding the telogen club hair (Figures 3(b) and
3(f)). Acantholysis led to a loss of the hair shaft followed
by formation of empty dermal cysts (Figures 3(d) and
3(h)). Nevertheless, the hair in these animals grew back
and was lost again in the next telogen phase. This cycle
repeated itself several times. Eventually, some of the older
mice remained bald, possibly due to hair follicle stem cell
depletion.
The patterned loss of hair is due to synchronization of
the hair cycle in mice; around the time of weaning hair
follicles progress from the ﬁrst postnatal anagen (the active
phase of hair growth cycle) to telogen (resting phase of
the hair growth cycle). Further, the wave of hair follicle
cycling proceeds from head to tail of the mouse. In rare
instances, hair loss has been reported in PF and PV patients
[5, 14], suggesting that the mouse models discussed here
mimic a human disease phenotype. However, due to the
synchronization of the mouse hair cycle (which does not
occur in humans), this eﬀe c ti sm u c hm o r es e v e r ei n
desmoglein and desmocollin null mice than in humans with
the autoimmune disease.
5. Dissectingthe Roles of Desmosomal
CadherinsinCellAdhesion, Signaling,
andSkin Disorders
The Dsg3 null mice do not develop an autoimmune disease;
that is, they do not provide us with a tool to dissect
autoantibody-mediated pathology. Nevertheless, these mice
enabled us for the ﬁrst time to link the loss of DSG3
function to PV histopathology. In other words, we were
able to functionally identify DSG3 as a likely key tar-
get in a subset of pemphigus patients. Subsequent to
the development of the Dsg3-null mouse model, Amagai
and colleagues utilized this mouse line to develop an
autoimmune model for PV in mice [15], demonstrating
the usefulness of genetically engineered mouse models for
understanding the molecular pathology of human diseases.
Nevertheless, the mechanism by which PV autoantibod-
ies induce loss of DSG3 function and cause PV is still
a controversial issue. The hypotheses range from direct
inhibition of desmoglein function to indirect loss of cell-
cell adhesion. For instance, PV antibodies appear to trig-
ger aberrant intracellular signaling in several pathways.
Several reports have provided a link between pemphigus
and abnormal signaling mediated by p38 MAPK pathway
and by plakoglobin ([16, 17], see [3]). Based on studies
that used cultured keratinocytes, it appears that pemphi-
gus autoantibodies trigger phosphorylation of p38 MAPK
which in turn induces acantholysis by aﬀecting downstream
eﬀectors such as RhoA or HSP27 [16, 18]. Interestingly,
inhibitors of p38 MAPK activation could prevent skin blister
formation in newborn mice injected with PV autoantibodies
(passive antibody transfer model for PV), which suggests
that signaling mechanisms involving p38 MAPK are central
to acantholysis in pemphigus. Results from another group
implicated depletion of the cellular plakoglobin pool leading
to increased expression of c-Myc to be critical for PV
pathogenesis [17, 19]. Although the role of c-Myc signaling
in acantholysis is not clearly understood, the fact that c-
Myc inhibitors abrogated skin blistering induced by PV
autoantibodies illustrates that this mechanism could be
important in PV pathogenesis. It, therefore, appears that the
mechanisms driving the loss of cell adhesion by impaired
desmosomal function are more complex than previously
believed.
Although it has been well established that DSG3 plays
a key role in the development of PV, less is known about
a potential role of desmocollins in autoimmune diseases.
DSC1 has been linked to IgA pemphigus (see [3]), whereas
a role for DSC3 in autoimmune diseases has not yet been
established. The phenotypic consequences of a Dsc3 null
mutation in stratiﬁed epithelia of mice suggest that loss of
function of this protein, either due to mutations or due
to autoantibodies, would result in PV-like lesions. Recent
reports suggest that this might indeed be the case. Bolling
and colleagues reported the case of a patient with PV-
like symptoms who had developed DSC3- but not DSG3-
autoantibodies [20]. This report did not establish, however,
whether the DSC3-speciﬁc antibodies from this patient were
pathogenic. Further, Ayub and colleagues recently reported
a DSC3 mutation in a family in Afghanistan that was
associated with hair loss and recurrent skin blistering [21],
thatis,aphenotypestrikinglysimilartothephenotypeofour
Dsc3 mutant mice. Nevertheless, this report did not provide
histological data demonstrating intraepidermal blistering;
that is, further evidence is required to convincingly link
impaired DSC3 function to intraepidermal blistering in
humans.
Taken together, our mouse study demonstrated that loss
of Dsc3 function can lead to PV-like lesions while the human
studies cited above suggest that this ﬁnding is relevant for
at least a subgroup of patients with PV-like disease. Further
studies will be necessary to determine the extent to which
DSC3 plays a role in inherited and acquired desmosomal







Figure 3: Hair loss phenotype of conditional Dsc3 null ((a), (b), (c), (d)) and conventional Dsg3 null mice ((e), (f), (g), (h)). Both mouse
lines show cyclic hair loss beginning around the time of weaning when the hair follicles on the back of the head enter telogen, the resting
phase of the hair growth cycle. (a) Hair loss of a 56-day-old conditional Dsc3 null mouse and (b) a 53-day-old Dsg3 null mouse. (b and f)
Acantholysis between the two cell layers surrounding the telogen hair club leads to loss of the hair shaft. Arrows indicate separation of the
two cell layers. Note that early lesions are shown, that is, before the hair shaft is actually lost. (c and g) Telogen hairs with a single epithelial cell
layer surrounding the club hair (brackets, nuclei of the epithelial sheet surrounding the clubs are stained in dark (c) and light (g) blue, resp.).
In both cases, hair loss leads to the development of dermal cysts ((d and h); stars). Note that the hair loss in both mouse lines appears to
follow the same mechanism, that is, loss of cell-cell adhesion between the two epithelial cell layers which anchor the telogen hair in the skin.
6. Conclusions
The last decade has seen a surge of information regarding
the roles of individual desmosomal genes in normal devel-
opment and diseases based on the analysis of transgenic
and knockout mice. The ability to switch genes on or
oﬀ in speciﬁc cell types and tissues at predetermined
time points has made the mouse model a premier tool
for discovering gene functions and for the elucidation of
disease mechanisms. Moreover, the core genetic and phys-
iologic pathways that control epithelial cell diﬀerentiation
(including appendage development) are highly conservedDermatology Research and Practice 7
between humans and mice. Although the ease of genetic
manipulations and the resemblance to human physiology
make mice an attractive choice to study skin disorders, there
arepotentialpitfalls,suchasthepossibilityofspecies-speciﬁc
diﬀerences in the histology of the skin. Further, it is also
not possible to exclude the existence of species-speciﬁc gene
functions, requiring conﬁrmation of experimental results in
a human test system. Nevertheless, the mouse will remain
a valuable tool for the analysis of human diseases and for
the advancement in our understanding of basic epithelial cell
biology.
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